Somatic recombination: A major genotoxic effect of two pyrimidine antimetabolitic chemotherapeutic drugs in Drosophila melanogaster

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 514, Issue 1-2, 2002, Pages 95-103

  Cunha, Kênya Silva ^a   Reguly, Maria Luíza ^b   Graf, Ulrich ^c   De Andrade, Heloisa Helena Rodrigues ^b  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c ETH ZURICH   (Switzerland)

Author keywords

1 D Arabinofuranosylcytosine; 5 aza 2 Deoxycytidine; Drosophila melanogaster; Genotoxicity; Somatic recombination

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ANTIINFECTIVE AGENT; CYTARABINE; DEOXYCYTIDINE; PYRIMIDINE DERIVATIVE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CELL DIVISION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA METHYLATION; DROSOPHILA MELANOGASTER; EXPOSURE; FEEDING; FEMALE; GENE MUTATION; GENOTOXICITY; LARVA; MALE; MOLECULAR CLONING; MUTANT; NONHUMAN; NUCLEIC ACID SYNTHESIS; PRIORITY JOURNAL; RECOMBINANT DNA TECHNOLOGY; STANDARDIZATION;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; CYTARABINE; DROSOPHILA MELANOGASTER; FEMALE; MALE; MOLECULAR STRUCTURE; MUTAGENICITY TESTS; RECOMBINATION, GENETIC;

DROSOPHILA MELANOGASTER; MELANOGASTER;

EID: 0037083002     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(01)00326-6     Document Type: Article

References (57)

1. Cytidine analogues
2. Metabolism of pyrimidine analogues and their nucleosides
3. Antimetabolites
4. 5-aza-2′-Deoxycytidine: An overview
5. Treatment of sickle-cell-anaemia with 5-azacytidine results in increased fetal hemoglobin production and is associated with nonrandom hypomethylation of DNA around the gamma-delta-beta-globin gene complex
6. 5-aza-2′-Deoxycytidine induces terminal differentiation of leukemic blasts from patients with acute myeloid leukemias
7. 5-aza-2′-Deoxycytidine (decitabine) and 5-azacytidine in the treatment of acute myeloid leukemias and myelodysplastic syndromes - Past, present and future trends
8. Effects of cytosine arabinose, daunomycin, mithramycin, 5-azacytidine, adriamycin and camptothecin on mammalian cell cycle traverse
9. Kinetic and template studies with 1-β-D-arabinofuranosylcytosine 5′-triphosphate and mammalian deoxyribonucleic acid polymerase
10. Synergistic action of 5-aza-2′-deoxycytidine and 3-deazauridine on L1210 leukemic cells and EMT6 tumour cells
11. Kinetics of deamination of 5-aza-2′-deoxycytidine and cytosine arabinoside by human liver cytidine deaminase and its inhibition by 3-deazauridine, thymidine and uracil arabinoside
12. Inhibition of DNA methylation in L1210 leukemic cells by 5-aza-2′-deoxycytidine as a possible mechanism of chemotherapeutic action
13. Antileukemic activity of 5-aza-2′-deoxycytidine and cytarabine against intracerebral L1210 murine leukaemia
14. Comparison of the antileukemic activity of 5-aza-2′-deoxycytidine, 1-β-D-arabinofuranosylcytosine and 5-aza-cytidine against L1210 leukemia
15. Effects of 5-aza-2′-deoxycytidine on survival and cell cycle progression of L1210 leukemic cells
16. Pharmacokinetics of 5-aza-2′-deoxycytidine in animals and man: Relevance to clinical trials
17. The role of DNA polymerases α, β and γ in nuclear DNA synthesis
18. A critical review of permeabilized cell systems for studying mammalian DNA repair
19. Evidence for a new mechanism of cytotoxicity of 1-β-D-arabinofuranosylcytosine
20. Mechanism of 1-beta-D-arabinofuranosylcytosine-induced cell lethality
21. Effect of 1-beta-D-arabinofuranosylcytosine on cell viability, DNA-synthesis, and chromatid breakage in synchronized hamster fibrosarcoma cells
22. Accumulation of leukemic-cell DNA strand breaks with adriamycin and cytosine-arabinoside
23. Biochemical and cellular pharmacology of cytosine-arabinoside
24. Cytosine-arabinoside toxicity - Molecular events, biological consequences, and their implications
25. Induction of internucleosomal DNA fragmentation in human myeloid-leukemia cells by 1-beta-D-arabinofuranosylcytosine
26. Cancer chemotherapy and biological response modifiers: Principles and practice
27. araC: Cellular and molecular pharmacology
28. Mutagenicity of 5-aza-2′-deoxycytidine is mediated by the mammalian DNA methyltransferase
29. Role of estrogen receptor gene demethylation and DNA methyltransferase-DNA adduct formation in 5-aza-2′-deoxycytidine-induced cytotoxicity in human breast cancer cells
30. Comparison of the antileukemic activity of 5-aza-2′-deoxycytidine (5-aza-dC) and 1-β-D-arabinofuranosylcytosine in rats with araC resistant and sensitive myelocytic leukemia
31. Anticancer drugs: An underestimated risk or an underutilised resource in mutagenesis
32. Somatic mutation and recombination test in Drosophila melanogaster
33. Testing the mutagenicity of malondialdehyde and formaldehyde by the Drosophila mosaic and the sex-linked recessive lethal tests
34. The results of assays in Drosophila as indicators of exposure to carcinogens
35. Thirty compounds tested in the Drosophila wing spot test
36. Statistical methods to decide whether mutagenicity test data from Drosophila assays indicate a positive, negative or inconclusive result
37. Optimal experimental design and sample size for the statistical evaluation of data from somatic mutation and recombination tests (SMART) in Drosophila
38. Induction of somatic mutation and recombination by four inhibitors of eukaryotic topoisomerases assayed in the wing spot test of Drosophila melanogaster
39. Homologous recombination as a mechanism of carcinogenesis
40. Inhibition of DNA synthesis is a potent mechanism by which cytostatic drugs induce homologous recombination in mammalian cells
41. Effects of 5-azacytidine on somatic mutation in a soybean test system
42. Induction of topoisomerase I cleavage complexes by 1-beta-D-arabinofuranosylcytosine (araC) in vitro and in araC-treated cells
43. The suitability of the micronucleus assay in human lymphocytes as a new biomarker of excision repair
44. Cellular differentiation, cytidine analogs and DNA methylation
45. On the mechanism of inhibition of DNA cytosine methyltransferases by cytosine analogs
46. DNA hypomethylation causes an increase in DNAse-I sensitivity and an advance in the time of replication of the entire inactive X-chromosome
47. The response of eukaryotic topoisomerases to DNA damage
48. Abasic sites stimulate double-stranded DNA cleavage mediated by topoisomerase-II - DNA lesions as endogenous topoisomerase-II poisons
49. Apurinic sites are position-specific topoisomerase II poisons
50. Spontaneous DNA lesions poison human topoisomerase II alpha and stimulate cleavage proximal to leukemic 11q23 chromosomal breakpoints
51. DNA methylation and gene activity
52. Exploring and explaining epigenetic effects
53. DNA of Drosophila melanogaster contains 5-methylcytosine
54. 5-Azacytidine induces micronuclei in and morphological transformation of syrian-hamster embryo fibroblasts in the absence of unscheduled DNA-synthesis
55. Micronuclei induced by modulators of methylation-analogs of 5-azacytidine
56. The genotoxicity of the anti-cancer drug mitoxantrone in somatic and germ cells of Drosophila melanogaster